Floatz logo

Therapeutic Asset Ratings

368 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
pbp1510
Pancreatic Neoplasm
Prestige Biopharma LimitedP1/2CC (40)
Pertzye
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
Pancreatic Neoplasm
University of Kansas Medical CenterP1/2CC (40)
Precemtabart Tocentecan
Pancreatic Neoplasm
EMD Serono Research & Development Institute, Inc.P1/2CC (40)
Pucotenlimab
Pancreatic Neoplasm
Zhejiang Provincial People's HospitalP1/2CC (40)
rp-001
Pancreatic Neoplasm
Recurv Pharma IncP1/2CC (40)
Satricabtagene Autoleucel
Pancreatic Neoplasm
CARsgen Therapeutics Co., Ltd.P1/2CC (40)
Shr-8068
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
Solnerstotug
Pancreatic Neoplasm
Sensei Biotherapeutics, Inc.P1/2CC (40)
sot102
Pancreatic Neoplasm
SOTIO Biotech a.s.P1/2CC (40)
Sotorasib
Pancreatic Neoplasm
Orion Corporation, Orion PharmaP1/2CC (40)
Tak-500
Pancreatic Neoplasm
TakedaP1/2CC (40)
tc-510
Pancreatic Neoplasm
TCR2 TherapeuticsP1/2CC (40)
T-Dxd
Pancreatic Neoplasm
AstraZenecaP1/2CC (40)
Tgfbr2 Ko Car27/Il-15 Nk Cells
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
Tifcemalimab
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
Trop2-Car-Nk
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
tt-4
Pancreatic Neoplasm
Tarus Therapeutics, Inc.P1/2CC (40)
vb15010
Pancreatic Neoplasm
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CC (40)
Vilamakitug
Pancreatic Neoplasm
XBiotech, Inc.P1/2CC (40)
Vodudeutentan sodium
Pancreatic Neoplasm
ENB Therapeutics, IncP1/2CC (40)
vrt106
Pancreatic Neoplasm
Guangdong Provincial People's HospitalP1/2CC (40)
Zimberelimab
Pancreatic Neoplasm
James Cleary, MD, PhDP1/2CC (40)
bi 765049
Pancreatic Neoplasm
Boehringer IngelheimP1C (39)
Cabotamig
Pancreatic Neoplasm
Arbele Pty LtdP1C (39)
Showing 201 to 225 of 368 assets
PreviousPage 9 of 15Next